BSAC Spring Conference & AGM
Addressing the AMR burden in everyday practice
18-19 May 2023
QEII Conference Centre London & online
Welcome to the BSAC Spring Conference
Welcome to the BSAC Spring Conference & AGM 2023: Addressing the AMR burden in everyday practice
Registration and abstract submission is now open for our annual two-day meeting which will be held at the QEII Conference Centre, London and online.
All accepted abstracts will be published in JAC-Antimicrobial Resistance.
This conference is RCPath CPD accredited.
For all enquiries, please contract Esme Carruthers
Programme
0830
0930
1400
1030
0330
Registration & coffee
0920
1020
1450
1120
0420
Welcome and opening remarks
Dr David Jenkins, Consultant Medical Microbiologist, Infection prevention Doctor, University Hospitals of Leicester NHS Trust & BSAC President - View Bio
SESSION ONE: Emerging, imported and forgotten infections
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection prevention Doctor, University Hospitals of Leicester NHS Trust & BSAC President - View Bio
0925
1025
1455
1125
0425
Management of imported infections - CPE from Ukranian casualties treated in The Netherlands
Dr Daan Notermans, Medical Microbiologist, Dutch National Institute for Public Health and the Environment (RIVM) - View Bio
0945
1045
1515
1145
0445
Tuberculosis - programmatic testing and treatment for latent tuberculosis in migrants
Professor Ajit Lalvani, NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London - View Bio
1005
1105
1535
1205
0505
Group A streptococcus pleural empyema in children
Dr Thomas Christie Williams, Wellcome Trust ECAT Clinical Lecturer, The University of Edinburgh & Registrar in Respiratory Paediatrics at the Royal Hospital for Children, Glasgow - View Bio
1025
1125
1555
1225
0525
Q&A
1035
1135
1605
1235
0535
BREAK, EXHIBITION & POSTER VIEWING
SESSION TWO: Recording AMR as primary cause or contributory cause of death
Chair: Mr David Aaronovitch, Journalist, The Times
1105
1205
1635
1305
0605
Death certification and AMR
Dr Alan Fletcher, National Medical Examiner for England and Wales - View Bio
1125
1225
1655
1325
0625
Balancing the opportunity and risk: the political importance of making this happen
Professor Dame Sally Davies, UK Government Special Envoy on Antimicrobial Resistance, UK Department of Health and Social Care - View Bio
1145
1245
1715
1345
0645
What education, training and advocacy is now needed?
Dr David Jenkins, Consultant Medical Microbiologist, Infection prevention Doctor, University Hospitals of Leicester NHS Trust & BSAC President - View Bio
1205
1305
1735
1405
0705
Panel discussion
SESSION THREE: Invited lectures
1225
1325
1755
1425
0725
New models of antimicrobial funding in England
Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
1245
1345
1815
1445
0745
UKAR update
Professor Gareth Jones, Professor in Epidemiology at the University of Aberdeen and Co-Chief Investigator of the UK Antimicrobial Registry - View Bio
1305
1405
1835
1505
0805
Q&A
1315
1415
1845
1515
0815
LUNCH, EXHIBITION & POSTER VIEWING
1320
1420
1850
1520
0820
BSAC AGM
SESSION FOUR: SUPPORTED SESSION
Supported by: Shionogi
1415
1515
1945
1615
0915
Supported presentation
SESSION FIVE: Fungal infection challenges
1500
1600
2030
1700
1000
Systemic fungal infections - the stewardship challenges
Ms Laura Whitney, NHSE
1520
1620
2050
1720
1020
Implementation of an antifungal stewardship program and the impact on a stem cell transplant centre
Mr Richard Wilson, Research Pharmacist, Imperial College London - View Bio
1540
1640
2110
1740
1040
Presentation to be confirmed
1600
1700
2130
1800
1100
Q&A
SESSION SIX: SUPPORTED SESSION
Supported by: Pfizer
1615
1715
2145
1815
1115
Supported presentation
SESSION SEVEN: Keynote Lecture
Chair: Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
1650
1750
2220
1850
1150
Rethinking AMS: New ideas for appropriate access from India
Dr Ramanan Laxminarayan, President of the One Health Trust, Senior Research Scholar, Princeton University - View Bio
1710
1810
2240
1910
1210
Q&A
1720
1820
2250
1920
1220
Day 1 - closing remarks
Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
1930
2030
0100
2130
1430
Conference dinner - by invitation
0730
0830
1300
0930
0230
Registration & coffee
SESSION EIGHT: CLINICAL LESSONS
Chair: Dr Helena Parsons Consultant Microbiologist, Sheffield Teaching Hospitals - View Bio
0800
0900
1330
1000
0300
To be selected from abstracts
0815
0915
1345
1015
0315
To be selected from abstracts
0830
0930
1400
1030
0330
To be selected from abstracts
0845
0945
1415
1045
0345
To be selected from abstracts
SESSION NINE: Penicillin allergy de-labelling
0900
1000
1430
1100
0400
How do we translate policy to practice in the UK
Dr Louise Savic, Leeds Teaching Hospitals
0920
1020
1450
1120
0420
Penfast study - lessons from Australia
Associate Professor Jason Trubiano, Infectious Diseases Physician & NHMRC Early Career Researcher, University of Melbourne, Department of Medicine (Austin Health
0940
1040
1510
1140
0440
Q&A
SESSION TEN: Invited lecture
Chair: Professor Tim Walsh, University of Oxford - View Bio
1000
1100
1530
1200
0500
Nothing changes unless it changes: The role of rapid diagnostics in hepatology
Dr Vishal Patel, Consultant Hepatologist, Liver Unit, King's College Hospital London & Principal Investigator, The Roger Williams Institute of Hepatology, Foundation for Liver Research
1020
1120
1550
1220
0520
Q&A
1030
1130
1600
1230
0530
REFRESHMENT BREAK, POSTER VIEWING
SESSION ELEVEN: SUPPORTED SESSION
Supported by: Cepheid
1100
1200
1630
1300
0600
Supported presentation
SESSION TWELVE: Sustainability and innovation: Securing the future of antimicrobials
Chair: Dr Aimee Murray, Senior Lecturer, University of Exeter - View Bio
1135
1235
1705
1335
0635
Achieving sustainable antimicrobial usage: exploring the “how” from a systems perspective
Dr Kelly Thornber, Research Fellow, University of Exeter - View Bio
1155
1255
1725
1355
0655
The post treatment impact of antimicrobials in the environment – a threat to yet be understood?
Professor William Gaze, University of Exeter
1215
1315
1745
1415
0715
Presentation title to be confirmed
Mr Tom Taylor, Head of climate finance, Aviva
1235
1335
1805
1435
0735
Q&A
SESSION THIRTEEN: SUPPORTED SESSION
Supported by: Pfizer
1300
1400
1830
1500
0800
Supported presentation
1330
1430
1900
1530
0830
LUNCH, NETWORKING & POSTER VIEWING
SESSION FOURTEEN: SUPPORTED SESSION
Supported by: Thermo Fisher
1410
1510
1940
1610
0910
Supported presentation
SESSION FIFTEEN: Alternative approaches and preventative measures
1445
1545
2015
1645
0945
Presentation to be confirmed
1505
1605
2035
1705
1005
Faecal transplants
Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust - View Bio
1525
1625
2055
1725
1025
Do it simple, do it well: reducing infection through low cost preventative measures
Professor Tim Walsh, University of Oxford - View Bio
1545
1645
2115
1745
1045
Q&A
SESSION SIXTEEN: To be confirmed
1600
1700
2130
1800
1100
Presentation to be confirmed
1615
1715
2145
1815
1115
Presentation to be confirmed
1630
1730
2200
1830
1130
Q&A
1645
1745
2215
1845
1145
Closing remarks
Registration
Registration is now open for either in-person or virtual attendance, please register using the links below.
For any questions regarding registration, please contact Esme Carruthers.
£160
BSAC Members (NHS/not for profit)
Full conference
£80
BSAC Members (NHS/not for profit)
One day
£200
Non-members (NHS/not for profit)
Full conference
£100
Non-members (NHS/not for profit)
One day
£400
Commercial
Full conference
£200
Commercial
One day
£50
Student & LMIC concessions
Full conference
£25
Student & LMIC concessions
One day
Abstracts
Please submit your abstract(s) using the online submission form for consideration for POSTER presentation at the conference.
Poster submission deadline: 1700hrs BST on Friday 14 April 2023
All accepted abstracts will be published in JAC-Antimicrobial Resistance.
Please note our Conditions of Submission:
- Abstracts must be submitted by the deadlines stated above. Submissions received after this time may not be considered.
- The first author should ideally be the presenting author. All correspondence will be sent to the lead author. The presenting author must register for the conference and can attend either in-person or virtually.
- If selected for poster presentation authors are required to submit their poster in pdf format prior to the conference.
- Accepted posters will be printed for the in-person element of the conference and also uploaded to the virtual platform.
- All abstracts need to be submitted using the online submission form. Please use the Supporting documents button to upload your full abstract in a Word file.
Format of Abstracts:
Abstract should be no longer than 400 words and contain:
- author affiliations
- an initial statement of specific objectives of the study, unless this is given in the title;
- a brief statement of methods;
- a summary of the results obtained;
- specific conclusions.
For any queries regarding abstract submissions, please contact Esme Carruthers.
Abstract submission
Sponsors
There are various sponsorship opportunities available at this conference, please contact Esme Carruthers for further details.
© 2023, British Society for Antimicrobial Chemotherapy. All Rights Reserved.
53 Regent Place, Birmingham B1 3NJ
Registered Charity 1093118